Grilled Cheese

ExploreLog inSign up
Terms of UsePrivacy PolicyCommunity StandardsHelpGet the app

Grilled Cheese is a product of Village Compute

Version devBuilt at: 2026-10-10 01:38:52 EDT

Explore

PostsPeople
LatestRanked
@gmj-georgia.bsky.socialOct 10, 2026, 1:26 PM

🔬 New hope for type 1 diabetes: First-in-human trial of immune-engineered cell therapy aims to replace daily insulin injections with a single transplant—… #Celltherapy #Clinicaltrial #Stemcells #Transplantation #Type1diabetes #Celltherapy #Clinicaltrial #Stemcells #Transplantation #Type1diabete…

@newsramp.comOct 9, 2026, 5:53 PM

FamiCord's Bramble Bio has signed a manufacturing deal with VERIGRAFT to produce personalized tissue-engineered vein P-TEV for the pivotal Phase II/III trial TECVI-2, valued in the low single-digit millions of euros. Trial expected to begin Q1 2027. #CDMO #CellTherapy

Image from article
@newsramp.comOct 9, 2026, 5:47 PM

Creative Biolabs launches an AI-assisted CAR/TCR development platform integrating target discovery, construct engineering, and safety profiling to help researchers cut screening time and improve candidate selection. #CellTherapy #CART

Image from article
@imtadvances.bsky.socialOct 9, 2026, 11:00 AM

A simple whole-blood assay enables rapid, in vivo monitoring of engineered TCR T cell function, capturing cytokine responses post-transfer without complex processing. A practical step for tracking cell therapy performance. 🧬

vist.ly/5mnx8

#Immunotherapy #Tcells #CellTherapy

Diagram showing HBV-TCR T cells infusion plan for HBV-HCC patient with timeline.
@drtimos.bsky.socialOct 8, 2026, 9:19 AM

🧬 Gene & Cell Therapy | #RareDiseases 🚀
#LucidQuest delivers sharp insights to help biotechs, investors & BD teams stay ahead in fast-moving markets.
📩 [email protected] or http://dlvr.it/TVqbST
#GeneTherapy #CellTherapy #Biotech #DueDiligence #InvestmentInsights

@wileylifesci.bsky.socialOct 7, 2026, 4:00 PM

Peacekeepers within your immune system, known as regulatory T cells, can now be reliably engineered in a lab.

This brings real hope for people with autoimmune disease and a greater chance of organ transplant success. #Immunology #CellTherapy

👉 Explore: https://bit.ly/3Thn8yA

A stethoscope and eyeglasses rest on a paper labeled "Immunology," which lists terms like CD4, CRP, and IgG. The text below reads, "Building better autoimmune treatments, brick by brick, in the lab" and "Barrier Immunity" with the Wiley logo above.
@wileyhealth.bsky.socialOct 7, 2026, 4:00 PM

Peacekeepers within your immune system, known as regulatory T cells, can now be reliably engineered in a lab.

This brings real hope for people with autoimmune disease and a greater chance of organ transplant success. #Immunology #CellTherapy

👉 Explore: https://bit.ly/4rERS9z

A stethoscope and eyeglasses rest on a paper labeled "Immunology," which lists terms like CD4, CRP, and IgG. The text below reads, "Building better autoimmune treatments, brick by brick, in the lab" and "Barrier Immunity" with the Wiley logo above.
@imtadvances.bsky.socialOct 7, 2026, 11:00 AM

A step forward in evolving cell therapies for AML: integrating TCR, CAR, BiTE, and safety switch into a single engineered T cell highlights how the field is moving toward multi-functional, adaptable designs to overcome tumor complexity.

vist.ly/5mcnu

#Immunotherapy #AML #CellTherapy

@coherentcmi.bsky.socialOct 6, 2026, 12:11 PM

Stem Cell Banking Market: Size, Trends, Growth, and Strategic Outlook

www.coherentcmi.com/market-insig...

#CellTherapy #Biobanking #CordBloodBanking #CellBanking #Biotechnology #HealthcareTechnology #LifeSciences #HealthcareMarket #MarketResearch #GlobalMarket

@theebmt.bsky.socialOct 6, 2026, 10:19 AM

📣 The EBMT Trainee Committee is welcoming new members to join a collaborative team of early-career professionals and young haematologists.

🔎 Learn more about the opportunity to amplify your impact and make sure to apply by 6 November: ebmt.org/ebmt/news/ap...

#hematology #HCT #celltherapy

@sigtrans-sttt.bsky.socialOct 3, 2026, 4:30 PM

Modulating #BACE1 transcription offers a different route to targeting #Amyloid pathology. Chlorhexidine suppresses BACE1 via a SOCS3-dependent JAK/STAT response, reducing amyloid pathology and cognitive deficits in AD models.

#STTT #OpenAccess: doi.org/10.1038/s413...
#CellTherapy

Transcriptional modulation of β-Secretase ameliorates amyloid pathology and cognitive deficits in Alzheimer’s disease models
@sigtrans-sttt.bsky.socialOct 3, 2026, 12:30 PM

Can gingiva-derived MSCs (GMSCs) help preserve β-cell function in #Type1Diabetes (#T1DM)? A phase 1 trial links GMSC therapy to improved residual β-cell function, potentially through CD8+ T-cell exhaustion.

#STTT #OpenAccess: doi.org/10.1038/s413...
#CellTherapy #BetaCellFunction

Safety and efficacy of human gingiva-derived mesenchymal stem cells in patients with type 1 diabetes: a double-blind, randomized, placebo-controlled, phase 1 trial
@drainteo.bsky.socialOct 3, 2026, 2:50 AM

Thankful for the feature in this issue of Stem Cell Reports' "Voices", together with many other eminent stem cell scientists (Shinya, Sonja, Hans, Hongmei, Laurent, Indumathi and Wei) globally.

#stemcells #iPSC #research #celltherapy #imcb #astar #NUS
www.cell.com/stem-cell-re...

@stemcell.comOct 2, 2026, 3:06 PM

Frequent culture interventions add operational risk to T cell manufacturing. Our low-intervention protocol pairs GMP ImmunoCult™ reagents with G-Rex® Bioreactors for scalable expansion with fewer manipulations.

Read the free protocol: https://bit.ly/4xPPs9D

#CellTherapy

@hesiglobal.bsky.socialOct 2, 2026, 2:01 PM

Register now: NIH and HESI Global hybrid workshop on cell and gene therapies!

View details and register: https://ow.ly/EOnh50ZTTgW

#HESIGlobal #CellTherapy #GeneTherapy #Biodistribution #TranslationalResearch #SafetyScience #collaboration

@longevitytech.bsky.socialOct 2, 2026, 1:14 PM

The maker of sasineprocel, a patient-derived cell therapy, has published its preclinical work in *Cell Stem Cell* as it heads toward Phase 3.

Link as first comment.

#longevity #geroscience #sasineprocel #celltherapy #stemcell

Illustration of legs walking with text about Parkinson's therapy Phase 3.
@moltherapy.bsky.socialOct 2, 2026, 12:15 PM

Registration is now open for the next Molecular Therapy Presents webinar, Beyond prevalence: How rare diseases are shaping therapeutic innovation. Learn more and register here today: http://dlvr.it/TVlH1Z

#RareDisease #GeneTherapy #CellTherapy #ASGCT

@jdevos.bsky.socialSep 30, 2026, 5:04 PM

BlueRock Therapeutics’ #iPSC-derived cell therapy lemiretprocel (OpCT-001) has received orphan drug designation from both the FDA and EMA for inherited retinal diseases.

Now in Phase 1/2a testing for retinitis pigmentosa, Usher syndrome & cone-rod dystrophies. #iPSC #CellTherapy

buff.ly/JjjdBgP

@ibb-uab.bsky.socialSep 30, 2026, 7:40 AM

📢 There is an open Postdoctoral Position in the Research Group led by Aura Muntasell to work on NK cell immunotherapy for cancer.

📄 All details can be found here: www.uab.cat/en/ibb/doc/2...

Feel free to share! 🧬

#Postdoc #Immunology #CancerResearch #CellTherapy #JobOpportunity

@longevitytech.bsky.socialSep 29, 2026, 3:32 PM

Resolution Therapeutics has treated its last EMERALD trial patient, putting macrophage-based therapy on track for results before year’s end.

Link as first comment.

#longevity #geroscience #macrophage #celltherapy #clinicaltrial

Glass liver model next to a blister pack of pills with text overlay.
Load more